Abeona Therapeutics (ABEO) Other Accumulated Expenses (2021 - 2025)
Historic Other Accumulated Expenses for Abeona Therapeutics (ABEO) over the last 5 years, with Q3 2025 value amounting to $35000.0.
- Abeona Therapeutics' Other Accumulated Expenses rose 340000.0% to $35000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $35000.0, marking a year-over-year increase of 340000.0%. This contributed to the annual value of $64000.0 for FY2024, which is 630000.0% up from last year.
- According to the latest figures from Q3 2025, Abeona Therapeutics' Other Accumulated Expenses is $35000.0, which was up 340000.0% from $80000.0 recorded in Q2 2025.
- In the past 5 years, Abeona Therapeutics' Other Accumulated Expenses ranged from a high of $317000.0 in Q1 2025 and a low of $1000.0 during Q4 2023
- Moreover, its 5-year median value for Other Accumulated Expenses was $80000.0 (2025), whereas its average is $123769.2.
- Per our database at Business Quant, Abeona Therapeutics' Other Accumulated Expenses plummeted by 9951.22% in 2024 and then soared by 3160000.0% in 2025.
- Quarter analysis of 5 years shows Abeona Therapeutics' Other Accumulated Expenses stood at $296000.0 in 2021, then tumbled by 31.08% to $204000.0 in 2022, then crashed by 99.51% to $1000.0 in 2023, then surged by 6300.0% to $64000.0 in 2024, then crashed by 45.31% to $35000.0 in 2025.
- Its Other Accumulated Expenses stands at $35000.0 for Q3 2025, versus $80000.0 for Q2 2025 and $317000.0 for Q1 2025.